Myc stabilization in response to estrogen and phospholipase D in MCF‐7 breast cancer cells
Open Access
- 18 September 2006
- journal article
- research article
- Published by Wiley in FEBS Letters
- Vol. 580 (24) , 5647-5652
- https://doi.org/10.1016/j.febslet.2006.09.013
Abstract
Estrogen, which has been strongly implicated in breast cancer, suppresses apoptosis in estrogen receptor (ER) positive MCF‐7 breast cancer cells. Phospholipase D (PLD), which is commonly elevated in ER negative breast cancer cells, also suppresses apoptosis. Survival signals generated by both estrogen and PLD are dependent upon elevated Myc expression. We report here that estrogen‐ and PLD‐induced increases in Myc expression are due to reduced turnover of Myc protein. Estrogen and PLD suppressed phosphorylation of Myc at Thr58 – a site that targets Myc for degradation by the proteasome. The data provide a mechanism for elevated Myc expression in hormone‐dependent and hormone‐independent breast cancer.Keywords
This publication has 37 references indexed in Scilit:
- Survival Signals Generated by Estrogen and Phospholipase D in MCF-7 Breast Cancer Cells Are Dependent on MycMolecular and Cellular Biology, 2005
- Phospholipase D confers rapamycin resistance in human breast cancer cellsOncogene, 2003
- c-MYC: more than just a matter of life and deathNature Reviews Cancer, 2002
- The Hallmarks of CancerCell, 2000
- MYC oncogenes and human neoplastic diseaseOncogene, 1999
- Translational induction of the c-myc oncogene via activation of the FRAP/TOR signalling pathwayOncogene, 1998
- Increased phospholipase D activity in human breast cancerZeitschrift für Krebsforschung und Klinische Onkologie, 1997
- Phospholipase D2, a distinct phospholipase D isoform with novel regulatory properties that provokes cytoskeletal reorganizationCurrent Biology, 1997
- Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase BNature, 1995
- New light on Myc and Myb. Part I. Myc.Genes & Development, 1990